Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Catalyst Pharmaceutical Partners, Inc.    CPRX   US14888U1016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/18/2015 05/19/2015 05/20/2015 05/21/2015 05/22/2015 Date
3.41(c) 3.96(c) 4(c) 3.94(c) 3.96(c) Last
382 247 1 386 444 1 045 366 638 602 347 019 Volume
+2.71% +16.13% +1.01% -1.50% +0.51% Change
More quotes
Financials ($)
Sales 2015 -
EBIT 2015 -30,5 M
Net income 2015 -31,3 M
Debt 2015 -
Yield 2015 -
Sales 2016 12,2 M
EBIT 2016 -26,4 M
Net income 2016 -24,5 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 0
Capi. / Sales 2016 26,6x
Capitalization 325 M
More Financials
Company
Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.The company has three drug candidates in development: Firdapse, CPP-115 and CPP-109.Catalyst Pharmaceutical Partners was... 
More about the company
Surperformance© ratings of Catalyst Pharmaceutical Pa
Trading Rating : Investor Rating : -
More Ratings
Latest news on CATALYST PHARMACEUTICAL PA
05/12 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces First Quarter 2015 ..
05/11 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces First Quarter 2015 ..
05/05 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals to Hold First Quarter Financi..
05/04 Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporat..
04/14 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Oral Presentation o..
04/14 Catalyst Pharmaceuticals Announces Oral Presentation of Firdapse Phase 3 Tria..
03/27 CATALYST PHARMACEUTICAL PARTNERS : Entry into a Material Definitive Agreement, F..
03/17 CATALYST PHARMACEUTICAL PARTNERS : Pharmaceuticals Announces Fourth Quarter and ..
More news
Sector news : Bio Therapeutic Drugs
05/22 SYNAGEVA BIOPHARMA : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investiga..
05/22 BLUEBIRD BIO : Announces Participation at the Jefferies 2015 Global Healthcare C..
05/21 ABBVIE : specifies breakdown of $21 billion Pharmacyclics deal
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/19 Midday Gainers / Losers
05/11 Catalyst Pharmaceutical beats by $0.02
04/27 Market Exclusivity Is Sometimes Too Much
04/24 Midday Gainers / Losers
03/16 Catalyst Pharma Q4 and FY14 results


Comments 
Advertisement
Chart CATALYST PHARMACEUTICAL PA
Duration : Period :
Catalyst Pharmaceutical Pa Technical Analysis Chart | CPRX | US14888U1016 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions